PlantNAT

PlantNAT is a biotechnology company focused on developing a novel class of RNA-based therapeutics that leverage natural antisense transcripts (NATs) to regulate gene expression. The company's proprietary platform identifies and targets specific NATs to upregulate the expression of proteins that are deficient in various genetic diseases. By utilizing the cell's own regulatory mechanisms, PlantNAT aims to provide precise and durable treatments for conditions that are currently difficult to address with traditional gene therapies or small molecules. Their approach is particularly suited for haploinsufficiency disorders where increasing the output of a single functional allele can restore health. The company is currently advancing several pre-clinical programs across multiple therapeutic areas.